According to LabCorp's latest financial reports the company's current EPS (TTM) is $7.52. In 2022 the company made an earnings per share (EPS) of $13.93 a decrease over its 2021 EPS that were of $24.58.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $7.52 | -46.02% |
2022 | $13.93 | -43.33% |
2021 | $24.58 | 54.11% |
2020 | $15.95 | 89.43% |
2019 | $8.42 | -3.33% |
2018 | $8.71 | -29.7% |
2017 | $12.39 | 75.74% |
2016 | $7.05 | 63.19% |
2015 | $4.32 | -28.4% |
2014 | $6.03 | -6.13% |
2013 | $6.43 | 5.2% |
2012 | $6.11 | 17.59% |
2011 | $5.20 | -4.51% |
2010 | $5.44 | 6.4% |
2009 | $5.11 | 20.89% |
2008 | $4.23 | 3.93% |
2007 | $4.07 | 16.62% |
2006 | $3.49 | 20.34% |
2005 | $2.90 | 11.54% |
2004 | $2.60 | 16.07% |
2003 | $2.24 | 25.14% |
2002 | $1.79 | 38.22% |
2001 | $1.30 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
IDEXX Laboratories IDXX | $9.91 | 31.78% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $6.76 | -10.11% | ๐บ๐ธ USA |
NeoGenomics
NEO | -$0.92 | -112.23% | ๐บ๐ธ USA |
Qiagen QGEN | $1.45 | -80.66% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | -$0.94 | -112.50% | ๐บ๐ธ USA |